In recent years, with the discovery of bio-molecular similarities between IPF and lung cancer and the role of the PD-1/PD-L1 axis in cancer immunity, more and more studies have begun to focus on the role of the PD-1/PD-L1 axis in IPF. This evidence concerns the gene RPL17 and lung carcinoma.